Hemodynamic parameters evaluated before inhalation (trough drug effect) improved or remained stable for the iloprost group versus significant deterioration in the placebo group when compared with baseline (10% increase in PVR, a 5% decrease in CO, and a 5% decrease in SVO2
over 12 weeks in the placebo group).
The SC 8000 also features an integrated serial interface as well as integration of data from up to four external devices, such as ventilators, SvO2
monitors, anesthesia machines, and respiratory gas monitors via the MIB Standard IEEE 1073 protocol.
Since the mid 1980's, Century has demonstrated particular success in the Japanese market with commercialization of new and emerging technologies including Continuous SvO2
Monitoring and Pulse Oximetry.